PubMed Health⌕ Search

Biomedical subjects

Heather Conrad

Publications and source records attributed to Heather Conrad.

3 recordsLinked to original sources

Emergency medical services system changes reduce pediatric epinephrine dosing errors in the prehospital setting.

OBJECTIVE: The goal was to describe the change in the rate of epinephrine dosing errors in the treatment of pediatric patients in prehospital cardiopulmonary arrest after the Los Angeles County Emergency Medical Services Agency instituted a program in which paramedics were required to use the Broselow tape and to report color zone categories to the base station and base stations were given and instructed formally in the use of the color-coded drug dosing chart. METHODS: An observational analysis of a natural experiment was performed. Children < or = 12 years of age who were determined to be in prehospital cardiopulmonary arrest and who received prehospital epinephrine treatment by paramedics, in the periods of 1994 to 1997 and 2003 to 2004, were included in the study. RESULTS: In the 1994 to 1997 cohort, we identified 104 subjects in prehospital cardiopulmonary arrest who received epinephrine with a documented weight and route of administration. Only 29 of 104 subjects in the 1994 to 1997 cohort received the correct dose, whereas 46 of 104 subjects received a first dose within 20% of the correct dose. In the 2003 to 2004 cohort, we identified 41 children < or = 12 years of age who were in cardiopulmonary arrest and received prehospital epinephrine treatment but 4 children were excluded, leaving 37 subjects. Twenty-one of 37 subjects received the correct dose, whereas 24 of 37 subjects received a dose within 20%. The odds ratio for obtaining the correct epinephrine dose after the system changes versus before was 3.0, and that for obtaining a dose within 20% of the correct dose was 2.5. CONCLUSIONS: The program seems to have resulted in reduction of the rate of epinephrine dosing errors in the prehospital treatment of children in cardiopulmonary arrest in Los Angeles County.

Adrenergic Agonists↗

A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.

The purpose of this study was to develop a model that investigates the biology of prostate cancer (PCA) that is metastatic to the bone, while closely approximates the clinical presentation of this disease. Human prostate cancer PC-3 cells were transfected with the neolacZ retrovirus. Then, eight-week-old SCID mice were injected subcutaneously with a single dose of PC-3 neolacZ cells. When the mice developed tumors at the injection site, they were sacrificed to harvest tumor fragments. One tumor fragment from a single PC-3 neolacZ injected animal was implanted into the prostates of five SCID mice. The SCID mice had all been previously grafted with adult human bone. Mice were sacrificed and tumor growth and metastasis to murine tissues as well as to the human bone graft were sought. The histologic samples were stained with X-Gal. In three mice tumors metastasized to the skeletal system. One animal showed limited X-Gal staining of the cells surrounding the human bone implant. In two mice tumors metastasized to liver and kidney and one metastasized to the lung. In this study we established a spontaneous bone metastasis model of human PCA cells with the combination of lacZ expression and orthotopic implantation of the PC-3 implanted tumor fragments. This model offers potential advantages in monitoring the metastatic pattern and behavior of prostate cancer and may be used to selectively study its interaction with human bone.

Animals↗